About: Dendritic cells require maturation via CD40 to generate protective antitumor immunity

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Dendritic cells require maturation via CD40 to generate protective antitumor immunity Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 September 1998

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована у вересні 1998 (uk) im September 1998 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en setiembre de 1998 (ast) scientific article published on 01 September 1998 (en) գիտական հոդված հրատարակված 1998 թվականի սեպտեմբերի 1-ին (hy)
publication date	wds:Q77186016-31FCC20E-C9C6-423A-ACC2-B2ACCCB88F98
publication date	1998-09-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q77186016-2D4DE651-8CD3-41E8-BE22-3D56D9B99007
language of work or name	English
author name string	wds:Q77186016-57212928-F81E-41DD-9E2C-2895A23C6B30 wds:Q77186016-76B13EC7-293A-4FAE-B5F6-EFE124FC8FA6 wds:Q77186016-7E4B73B2-F4A6-4CF3-AFD1-F8B75CD500E3 wds:Q77186016-9CFACF8E-A181-4C5C-9694-8380D8CAAD57 wds:Q77186016-D95E8C98-E1A4-48BF-A994-78AFDFB6A3AE wds:Q77186016-DAD77EF4-1065-4092-A40B-021F795F6939
author name string	Kikutani H Barth RJ Jr Noelle RJ Gunn JR Mackey MF Maliszewsky C
rdfs:label	Dendritic cells require maturation via CD40 to generate protective antitumor immunity (en) Dendritic cells require maturation via CD40 to generate protective antitumor immunity (nl)
skos:prefLabel	Dendritic cells require maturation via CD40 to generate protective antitumor immunity (en) Dendritic cells require maturation via CD40 to generate protective antitumor immunity (nl)
name	Dendritic cells require maturation via CD40 to generate protective antitumor immunity (en) Dendritic cells require maturation via CD40 to generate protective antitumor immunity (nl)
title	wds:Q77186016-6D35A7C7-FB2B-4161-AA55-03345E301F4C
title	Dendritic cells require maturation via CD40 to generate protective antitumor immunity (en)
page(s)	wds:Q77186016-CE82886F-BA6B-4C35-A473-251EC11708BE
page(s)	2094-2098
instance of	wds:Q77186016-D33EC546-9360-4973-8FA7-EE4C2EB17096
instance of	scholarly article
main subject	wds:Q77186016-1ED509D2-B4A4-4017-8B8B-30BEB6BC324B
main subject	dendritic cell
PubMed ID	wds:Q77186016-1EC52C9B-E815-41D9-BFF4-DFCA0186B997
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/9725199
PubMed ID	9725199
published in	wds:Q77186016-96A357A7-4A0A-4C97-804F-669248C46D77
published in	Journal of Immunology
issue	wds:Q77186016-31BED986-B830-4EF8-8084-D599CD12C9AC
volume	wds:Q77186016-2CCEC831-80A5-4644-AC21-7623900EBA12
issue	5
volume	161
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q77186016
is cites work of	Why can't the immune system control HIV-1? Defining HIV-1-specific CD4+ T cell immunity in order to develop strategies to enhance viral immunity Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy Dendritic cells: In the forefront of immunopathogenesis and vaccine development - A review Altered Th1/Th2 commitment in human CD4+ T cells with ageing. TRANCE, a tumor necrosis factor family member, enhances the longevity and adjuvant properties of dendritic cells in vivo CD4 T cells and their role in antitumor immune responses Trial watch: Dendritic cell-based interventions for cancer therapy A push-pull approach to maximize vaccine efficacy: abrogating suppression with an IL-13 inhibitor while augmenting help with granulocyte/macrophage colony-stimulating factor and CD40L Tumor growth enhances cross-presentation leading to limited T cell activation without tolerance The role of CD40 and CD154/CD40L in dendritic cells Cytokine-mediated protection of human dendritic cells from prostate cancer-induced apoptosis is regulated by the Bcl-2 family of proteins Vpx-containing dendritic cell vaccine induces CTLs and reactivates latent HIV-1 in vitro A genetically engineered adenovirus vector targeted to CD40 mediates transduction of canine dendritic cells and promotes antigen-specific immune responses in vivo Distinct cytokine regulation by cholera toxin and type II heat-labile toxins involves differential regulation of CD40 ligand on CD4(+) T cells. Dendritic cells: immunological sentinels with a central role in health and disease. Trial watch: Dendritic cell-based interventions for cancer therapy Generation in vitro of B-cell chronic lymphocytic leukaemia-proliferative and specific HLA class-II-restricted cytotoxic T-cell responses using autologous dendritic cells pulsed with tumour cell lysate Melanoma immunotherapy by targeted IL-2 depends on CD4(+) T-cell help mediated by CD40/CD40L interaction High-affinity T helper epitope induces complementary helper and APC polarization, increased CTL, and protection against viral infection CD40-deficient dendritic cells producing interleukin-10, but not interleukin-12, induce T-cell hyporesponsiveness in vitro and prevent acute allograft rejection Interference of CD40L-mediated tumor immunotherapy by oncolytic vesicular stomatitis virus. The role of ICAM-1 molecule in the migration of Langerhans cells in the skin and regional lymph node Dendritic cells for active anti-cancer immunotherapy: targeting activation pathways through genetic modification. CD40L expressed from the canarypox vector, ALVAC, can boost immunogenicity of HIV-1 canarypox vaccine in mice and enhance the in vitro expansion of viral specific CD8+ T cell memory responses from HIV-1-infected and HIV-1-uninfected individuals Trial watch: Dendritic cell-based anticancer therapy Significant alterations of biodistribution and immune responses in Balb/c mice administered with adenovirus targeted to CD40(+) cells T-cell-independent antitumor effects of CD40 ligation Dendritic cell biology and the application of dendritic cells to immunotherapy of multiple myeloma. Type-1 polarized dendritic cells primed for high IL-12 production show enhanced activity as cancer vaccines CD40 induces antigen transporter and immunoproteasome gene expression in carcinomas via the coordinated action of NF-kappaB and of NF-kappaB-mediated de novo synthesis of IRF-1. Tumor and Host Factors Controlling Antitumor Immunity and Efficacy of Cancer Immunotherapy CD40 signaling to the rescue: A CD8 exhaustion perspective in chronic infectious diseases Trial watch: Dendritic cell-based anticancer immunotherapy. Intravenously usable fully serotype 3 oncolytic adenovirus coding for CD40L as an enabler of dendritic cell therapy Tolerance-inducing strategies in islet transplantation Incorporation of CD40 ligand into the envelope of pseudotyped single-cycle Simian immunodeficiency viruses enhances immunogenicity. HIF1A (rs11549465) and AKNA (rs10817595) Gene Polymorphisms Are Associated with Primary Sjögren's Syndrome Bone marrow dendritic cells deficient for CD40 and IL-23p19 are tolerogenic in vitro Synthetic CpG-ODN rapidly enriches immune compartments in neonatal chicks to induce protective immunity against bacterial infections Mucosal delivery of CpG-ODN mimicking bacterial DNA via the intrapulmonary route induces systemic antimicrobial immune responses in neonatal chicks Targeting Melanoma with Cancer-Killing Viruses
is cites work of	wds:Q36604777-713D7B03-2495-4660-B97A-E6F8CCC653F4 wds:Q41815438-1C06E56F-2635-40FF-A0C1-066F1C96C16A wds:Q73128939-D88CA136-95ED-43A0-835E-CAD50B5F04A1 wds:Q28362580-5CDB3E1B-E99C-4FA7-A422-CE7B4AB8162F wds:Q27024047-714D1E3D-B8F5-4085-AD0C-166E43F72CD7 wds:Q24792153-77F58E01-C06C-4F16-99E0-0D44532C3B75 wds:Q33581766-1C5314AF-F9EB-48A2-A660-B0C5C35B7924 wds:Q36375923-C1DC7FA6-2976-44A7-A4B4-D48FF1875E9E wds:Q95642569-0B3D3B53-905D-41B4-A521-28C6A0174052 wds:Q30373512-051958F6-98BF-47F1-9737-8ACFFB70F272 wds:Q33890355-D4B7BD02-E253-4809-9296-F20EDC3FB602 wds:Q34433429-DD589C31-4944-4EFB-A31B-89A209A127CB

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software